Copyright & Trademark Law Community | LexisNexis
Featured Content

12/21/2012 10:52:58 AM EST

Allergan Rivals' Eyelash Treatments Are Drugs, Court Rules

Posted by

Law360: Intellectual Property

A California federal judge on Thursday granted summary judgment to Allergan Inc. on unfair competition claims over the alleged marketing of copycat versions of its eyelash treatment Latisse, ruling the rival companies' products should be considered drugs Read More...